Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Garmo

Showing results (71-80 of 261) with videos related to

Pageof 27
Sort By:
Plos One|December 28, 2020
Observational study on time on treatment with abiraterone and enzalutamideGiuseppe Fallara, Ingela Franck Lissbrant, Johan Styrke, et al.
JAMA Network Open|September 14, 2022
Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in SwedenEugenio Ventimiglia, Anna Bill-Axelson, Ola Bratt, et al.
JAMA Network Open|October 2, 2023
Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet TherapyChristian Corsini, Hans Garmo, Andri Wilberg Orrason, et al.
Plos One|April 13, 2018
A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0Beth Russell, Hans Garmo, Kerri Beckmann, et al.
Acta Oncologica (Stockholm, Sweden)|October 13, 2025
Radium-223 use and survival by line of treatment in metastatic castration-resistant prostate cancer: a nationwide population-based register studyCharlotte Alverbratt, Fredrik Sandin, Viktor Kolmbäck, et al.
Breast Cancer Research and Treatment|August 6, 2016
Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based studyAntonis Valachis, Hans Garmo, John Weinman, et al.
Drug and Alcohol Dependence|May 26, 2015
Anabolic steroids and cardiovascular risk: A national population-based cohort studyIngemar Thiblin, Hans Garmo, Mats Garle, et al.
BJU International|April 11, 2020
Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in SwedenAndri Wilberg Orrason, Marcus Westerberg, Hans Garmo, et al.
European Urology|October 14, 2019
Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort StudyRenata Zelic, Hans Garmo, Daniela Zugna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
Distribution of coronary artery stenosis after radiation for breast cancerGreger Nilsson, Lars Holmberg, Hans Garmo, et al.
Pageof 27

Showing results (71-80 of 261) with videos related to

Sort By:
Pageof 27
Plos One|December 28, 2020
Observational study on time on treatment with abiraterone and enzalutamideGiuseppe Fallara, Ingela Franck Lissbrant, Johan Styrke, et al.
JAMA Network Open|September 14, 2022
Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in SwedenEugenio Ventimiglia, Anna Bill-Axelson, Ola Bratt, et al.
JAMA Network Open|October 2, 2023
Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet TherapyChristian Corsini, Hans Garmo, Andri Wilberg Orrason, et al.
Plos One|April 13, 2018
A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0Beth Russell, Hans Garmo, Kerri Beckmann, et al.
Acta Oncologica (Stockholm, Sweden)|October 13, 2025
Radium-223 use and survival by line of treatment in metastatic castration-resistant prostate cancer: a nationwide population-based register studyCharlotte Alverbratt, Fredrik Sandin, Viktor Kolmbäck, et al.
Breast Cancer Research and Treatment|August 6, 2016
Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based studyAntonis Valachis, Hans Garmo, John Weinman, et al.
Drug and Alcohol Dependence|May 26, 2015
Anabolic steroids and cardiovascular risk: A national population-based cohort studyIngemar Thiblin, Hans Garmo, Mats Garle, et al.
BJU International|April 11, 2020
Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in SwedenAndri Wilberg Orrason, Marcus Westerberg, Hans Garmo, et al.
European Urology|October 14, 2019
Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort StudyRenata Zelic, Hans Garmo, Daniela Zugna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
Distribution of coronary artery stenosis after radiation for breast cancerGreger Nilsson, Lars Holmberg, Hans Garmo, et al.
Pageof 27